Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Solesence (SLSN) EBITDA (2016 - 2025)

Historic EBITDA for Solesence (SLSN) over the last 16 years, with Q3 2025 value amounting to -$781000.0.

  • Solesence's EBITDA fell 12442.15% to -$781000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 6640.65%. This contributed to the annual value of $5.1 million for FY2024, which is 24472.65% up from last year.
  • Solesence's EBITDA amounted to -$781000.0 in Q3 2025, which was down 12442.15% from $1.9 million recorded in Q2 2025.
  • Solesence's EBITDA's 5-year high stood at $3.2 million during Q3 2024, with a 5-year trough of -$1.9 million in Q4 2023.
  • For the 5-year period, Solesence's EBITDA averaged around $172368.4, with its median value being $123000.0 (2022).
  • As far as peak fluctuations go, Solesence's EBITDA soared by 125581.4% in 2021, and later plummeted by 105619.05% in 2023.
  • Solesence's EBITDA (Quarter) stood at -$299000.0 in 2021, then tumbled by 519.4% to -$1.9 million in 2022, then fell by 2.43% to -$1.9 million in 2023, then soared by 88.24% to -$223000.0 in 2024, then tumbled by 250.22% to -$781000.0 in 2025.
  • Its last three reported values are -$781000.0 in Q3 2025, $1.9 million for Q2 2025, and $256000.0 during Q1 2025.